Cel-Sci
CVM
#10574
Rank
โ‚ฌ30.45 M
Marketcap
1,73ย โ‚ฌ
Share price
-0.51%
Change (1 day)
-79.10%
Change (1 year)

EPS for Cel-Sci (CVM)

EPS in 2026 (TTM): -2,72ย โ‚ฌ

According to Cel-Sci 's latest financial reports the company's current EPS (TTM) is -2,84ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -5,60ย โ‚ฌ an increase over its 2024 EPS that were of -13,66ย โ‚ฌ.

EPS history for Cel-Sci from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-2,72ย โ‚ฌ-51.33%
2025-5,60ย โ‚ฌ-59.05%
2024-13,66ย โ‚ฌ-30.09%
2023-19,54ย โ‚ฌ-16.09%
2022-23,29ย โ‚ฌ-3.33%
2021-24,09ย โ‚ฌ9.76%
2020-21,95ย โ‚ฌ15.49%
2019-19,01ย โ‚ฌ-62.03%
2018-50,06ย โ‚ฌ2.19%
2017-48,99ย โ‚ฌ-22.78%
2016-63,45ย โ‚ฌ-77.45%
2015-281,37ย โ‚ฌ-13.14%
2014-323,94ย โ‚ฌ61.33%
2013-200,79ย โ‚ฌ-57.14%
2012-468,51ย โ‚ฌ-45.31%
2011-856,70ย โ‚ฌ-420%
2010267,72ย โ‚ฌ-112.9%
2009-2.075ย โ‚ฌ342.86%
2008-468,51ย โ‚ฌ-30%
2007-669,30ย โ‚ฌ-0%
2006-669,30ย โ‚ฌ150%
2005-267,72ย โ‚ฌ-0%
2004-267,72ย โ‚ฌ-75%
2003-1.071ย โ‚ฌ-54.29%
2002-2.343ย โ‚ฌ-31.37%
2001-3.413ย โ‚ฌ15.91%
2000-2.945ย โ‚ฌ-10.39%
1999-3.287ย โ‚ฌ-29.73%
1998-4.677ย โ‚ฌ-26%
1997-6.320ย โ‚ฌ-13.79%
1996-7.331ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,79ย โ‚ฌ-374.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
14,47ย โ‚ฌ-610.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-1,94ย โ‚ฌ-31.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-12,69ย โ‚ฌ 347.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
0,56ย โ‚ฌ-119.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
-1,29ย โ‚ฌ-54.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-3,07ย โ‚ฌ 8.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-26,14ย โ‚ฌ 821.07%๐Ÿ‡บ๐Ÿ‡ธ USA